Access cutting-edge hereditary angioedema treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access hereditary angioedema specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hereditary angioedema treatment provided free
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, 2-period, 2-treatment cross-over study to evaluate the efficacy and safety of orally administered deucrictibant compared to placebo for the on-demand treatment of HAE attacks, including non-severe laryngeal attacks, in participants ≥12 to ≤75 years of age with HAE type 1, type 2, or type 3, a proportion of whom are using long-term prophylactic medication for HAE.
Sponsor: Pharvaris Netherlands B.V.
Check if you qualify for this hereditary angioedema clinical trial in Birmingham, AL
If you're searching for hereditary angioedema treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hereditary angioedema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.